BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 23069914)

  • 1. Lyophilisomes as a new generation of drug delivery capsules.
    van Bracht E; Raavé R; Verdurmen WP; Wismans RG; Geutjes PJ; Brock RE; Oosterwijk E; van Kuppevelt TH; Daamen WF
    Int J Pharm; 2012 Dec; 439(1-2):127-35. PubMed ID: 23069914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific targeting of tumor cells by lyophilisomes functionalized with antibodies.
    van Bracht E; Stolle S; Hafmans TG; Boerman OC; Oosterwijk E; van Kuppevelt TH; Daamen WF
    Eur J Pharm Biopharm; 2014 May; 87(1):80-9. PubMed ID: 24463217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced cellular uptake of albumin-based lyophilisomes when functionalized with cell-penetrating peptide TAT in HeLa cells.
    van Bracht E; Versteegden LR; Stolle S; Verdurmen WP; Woestenenk R; Raavé R; Hafmans T; Oosterwijk E; Brock R; van Kuppevelt TH; Daamen WF
    PLoS One; 2014; 9(11):e110813. PubMed ID: 25369131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Graphene-based anticancer nanosystem and its biosafety evaluation using a zebrafish model.
    Liu CW; Xiong F; Jia HZ; Wang XL; Cheng H; Sun YH; Zhang XZ; Zhuo RX; Feng J
    Biomacromolecules; 2013 Feb; 14(2):358-66. PubMed ID: 23286342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Formulation, characterization and evaluation of curcumin-loaded PLGA nanospheres for cancer therapy.
    Mukerjee A; Vishwanatha JK
    Anticancer Res; 2009 Oct; 29(10):3867-75. PubMed ID: 19846921
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nano-sized albumin-copolymer micelles for efficient doxorubicin delivery.
    Wu Y; Shih EK; Ramanathan A; Vasudevan S; Weil T
    Biointerphases; 2012 Dec; 7(1-4):5. PubMed ID: 22589048
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodistribution of size-selected lyophilisomes in mice.
    van Bracht E; Raavé R; Perevyazko IY; Versteeg EM; Hafmans TG; Schubert US; Oosterwijk E; van Kuppevelt TH; Daamen WF
    Eur J Pharm Biopharm; 2015 Aug; 94():141-51. PubMed ID: 25953331
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lyophilisomes: Potential carriers for tumor targeting.
    van Bracht E; Geutjes PJ; Woestenenk R; Wismans RG; Oosterwijk E; van Kuppevelt TH; Daamen WF
    J Control Release; 2010 Nov; 148(1):e7-8. PubMed ID: 21529636
    [No Abstract]   [Full Text] [Related]  

  • 9. Polymeric micellar co-delivery of resveratrol and curcumin to mitigate in vitro doxorubicin-induced cardiotoxicity.
    Carlson LJ; Cote B; Alani AW; Rao DA
    J Pharm Sci; 2014 Aug; 103(8):2315-22. PubMed ID: 24914015
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergistic anti-cancer effects via co-delivery of TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) and doxorubicin using micellar nanoparticles.
    Lee AL; Dhillon SH; Wang Y; Pervaiz S; Fan W; Yang YY
    Mol Biosyst; 2011 May; 7(5):1512-22. PubMed ID: 21350763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Block co-polymer nanoparticles with degradable cross-linked core and low-molecular-weight PEG corona for anti-tumour drug delivery.
    Abraham G; McCarroll J; Byrne F; Saricilar S; Kavallaris M; Bulmus V
    J Biomater Sci Polym Ed; 2011; 22(8):1001-22. PubMed ID: 20566070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional Albumin Nanoformulations to Fight Adrenocortical Carcinoma: a Redox-Responsive Approach.
    Curcio M; Avena P; Cirillo G; Casaburi I; Spizzirri UG; Nicoletta FP; Iemma F; Pezzi V
    Pharm Res; 2020 Feb; 37(3):55. PubMed ID: 32060727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Curcumin-loaded biodegradable polymeric micelles for colon cancer therapy in vitro and in vivo.
    Gou M; Men K; Shi H; Xiang M; Zhang J; Song J; Long J; Wan Y; Luo F; Zhao X; Qian Z
    Nanoscale; 2011 Apr; 3(4):1558-67. PubMed ID: 21283869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of novel biodegradable methoxy poly(ethylene glycol)-zein micelles for effective delivery of curcumin.
    Podaralla S; Averineni R; Alqahtani M; Perumal O
    Mol Pharm; 2012 Sep; 9(9):2778-86. PubMed ID: 22770552
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A prodrug nanoassembly entrapping drugs as a tumor-targeted delivery system.
    Yuan Z; Yi X; Zhang J; Cheng S; Zhuo R; Li F
    Chem Commun (Camb); 2013 Jan; 49(8):801-3. PubMed ID: 23235958
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preparation, characterisation and maintenance of drug efficacy of doxorubicin-loaded human serum albumin (HSA) nanoparticles.
    Dreis S; Rothweiler F; Michaelis M; Cinatl J; Kreuter J; Langer K
    Int J Pharm; 2007 Aug; 341(1-2):207-14. PubMed ID: 17478065
    [TBL] [Abstract][Full Text] [Related]  

  • 17. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells.
    Yallapu MM; Jaggi M; Chauhan SC
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):113-25. PubMed ID: 20456930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of therapeutic activity of doxorubicin by long circulating liposomes in combination with curcumin.
    Wang H; Hu L; Li C; Zhang J; Zhang T
    Pharmazie; 2011 Nov; 66(11):871-4. PubMed ID: 22204133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles.
    Wang H; Zhao Y; Wu Y; Hu YL; Nan K; Nie G; Chen H
    Biomaterials; 2011 Nov; 32(32):8281-90. PubMed ID: 21807411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the extracellular matrix of ovarian cancer using functionalized, drug loaded lyophilisomes.
    van der Steen SC; Raavé R; Langerak S; van Houdt L; van Duijnhoven SM; van Lith SA; Massuger LF; Daamen WF; Leenders WP; van Kuppevelt TH
    Eur J Pharm Biopharm; 2017 Apr; 113():229-239. PubMed ID: 28034806
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.